MORGAN STANLEY - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 78 filers reported holding INOZYME PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$110,763
-40.8%
26,372
-21.5%
0.00%
Q2 2023$187,069
+68.7%
33,585
+73.5%
0.00%
Q1 2023$110,909
+703.5%
19,356
+47.2%
0.00%
Q4 2022$13,803
-76.6%
13,146
-41.0%
0.00%
Q3 2022$59,000
-70.1%
22,284
-45.9%
0.00%
Q2 2022$197,000
+207.8%
41,174
+158.4%
0.00%
Q1 2022$64,000
-51.9%
15,937
-18.0%
0.00%
Q4 2021$133,000
-36.4%
19,440
+8.0%
0.00%
Q3 2021$209,000
-71.3%
17,994
-57.9%
0.00%
Q2 2021$728,000
+49.8%
42,754
+74.2%
0.00%
Q1 2021$486,000
+20.0%
24,550
+24.9%
0.00%
Q4 2020$405,000
+1127.3%
19,653
+1471.0%
0.00%
Q3 2020$33,0001,2510.00%
Other shareholders
INOZYME PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,591,154$27,113,00010.69%
Burrage Capital Management LLC 242,517$4,132,0004.14%
CHI Advisors LLC 927,264$15,801,0003.68%
Sofinnova Investments, Inc. 2,028,308$34,562,0001.99%
Novo Holdings A/S 1,867,706$31,826,0001.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,178,985$37,130,0000.66%
RA Capital Management 2,003,653$34,142,0000.55%
NEA Management Company, LLC 2,444,379$41,652,0000.54%
Rock Springs Capital Management LP 840,272$14,318,0000.28%
SUVRETTA CAPITAL MANAGEMENT, LLC 365,172$6,223,0000.09%
View complete list of INOZYME PHARMA INC shareholders